As of January 1, 2023, the Inflation Reduction Act has capped out-of-pocket costs for insulin at $35 per month for all Medicare Part D enrollees. This significant change aims to alleviate the financial strain...
Archive - June 2025
In a historic move, Medicare has initiated negotiations with pharmaceutical companies to lower prices for high-cost prescription drugs. This effort, authorized by the Inflation Reduction Act, targets...
The State Health Insurance Assistance Program (SHIP) offers free, personalized counseling to help Medicare beneficiaries understand their coverage options. With the increasing complexity of Medicare plans...





